Cargando…

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis

The potential of autologous cell‐based therapies including those using multipotent mesenchymal stromal cells (MSCs) is being investigated for multiple sclerosis (MS) and other neurological conditions. However, the phenotype of MSC in neurological diseases has not been fully characterized. We have pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Heesom, Kate J, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	Translational Research Articles and Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186266/ https://www.ncbi.nlm.nih.gov/pubmed/30063300 http://dx.doi.org/10.1002/sctm.18-0045

Ejemplares similares

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
por: Sarkar, Pamela, et al.
Publicado: (2018)

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
por: Sarkar, Pamela, et al.
Publicado: (2021)

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum
por: Redondo, Juliana, et al.
Publicado: (2014)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
por: Redondo, Juliana, et al.
Publicado: (2017)

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)
por: Rice, Claire M, et al.
Publicado: (2015)

Reductions in kinesin expression are associated with nitric oxide-induced axonal damage
por: Redondo, Juliana, et al.
Publicado: (2015)

Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment
por: Witherick, Jonathan, et al.
Publicado: (2010)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2022)

Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells
por: Kemp, Kevin, et al.
Publicado: (2017)

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2016)

Erratum to: ‘Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia’
por: Kemp, Kevin C., et al.
Publicado: (2016)

Cell fusion in the brain: two cells forward, one cell back
por: Kemp, Kevin, et al.
Publicado: (2014)

Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts
por: Kemp, Kevin, et al.
Publicado: (2011)

Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
por: Kemp, Kevin C., et al.
Publicado: (2018)

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
por: Rice, Claire M., et al.
Publicado: (2015)

Percutaneous Endoscopic Gastrostomy Tube Insertion in Neurodegenerative Disease: A Retrospective Study and Literature Review
por: Sarkar, Pamela, et al.
Publicado: (2017)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
por: Gray, Elizabeth, et al.
Publicado: (2012)

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells
por: Kemp, Kevin C., et al.
Publicado: (2018)

Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model
por: Kemp, Kevin C., et al.
Publicado: (2017)

Mesenchymal Stromal Cells: Current Understanding and Clinical Status
por: Salem, Husein K, et al.
Publicado: (2010)

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells
por: Kemp, K, et al.
Publicado: (2011)

Concise Review: Exploring Immunomodulatory Features of Mesenchymal Stromal Cells in Humanized Mouse Models
por: Mehler, Vera J., et al.
Publicado: (2018)

Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation
por: Feng, Hao, et al.
Publicado: (2018)

Epigenetic dysregulation in meningiomas
por: Wedemeyer, Michelle A, et al.
Publicado: (2022)

Dysregulated bioenergetics: a key regulator of joint inflammation
por: Biniecka, M, et al.
Publicado: (2016)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro
por: Azevedo, Rita I., et al.
Publicado: (2020)

Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma
por: Liles, J S, et al.
Publicado: (2011)

Acceleration of Fracture Healing by Overexpression of Basic Fibroblast Growth Factor in the Mesenchymal Stromal Cells
por: Zhang, Hongliang, et al.
Publicado: (2017)

Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3‐Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2017)

Cell-based therapeutic strategies for multiple sclerosis
por: Scolding, Neil J, et al.
Publicado: (2017)

Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First‐in‐Man Study
por: Chambers, Daniel C., et al.
Publicado: (2017)

Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS
por: Forostyak, Serhiy, et al.
Publicado: (2014)

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
por: White, N M A, et al.
Publicado: (2010)

Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy
por: Sava, Ruxandra I., et al.
Publicado: (2020)

Concise Review: Quantitative Detection and Modeling the In Vivo Kinetics of Therapeutic Mesenchymal Stem/Stromal Cells
por: Brooks, Anastasia, et al.
Publicado: (2017)

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies
por: Augustine, Sajit, et al.
Publicado: (2017)

Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal Cells
por: Wang, Liyong, et al.
Publicado: (2020)

The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34(+) Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
por: Preciado, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vqio1ntdlqdolk8lh1nmu0233g